What is NDC 0078-0827?

0078-0827 is the product NDC for Beovu (brolucizumab), Brolucizumab 6 mg/.05mL injection, solution, listed with the FDA by Novartis Pharmaceuticals Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.

Novartis Pharmaceuticals Corporation, NDC labeler code 0078. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Beovu?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Beovu NDC 0078-0827 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0078-0827Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00078-0827Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0078-0827-60	00078082760	1 SYRINGE, GLASS in 1 CARTON (0078-0827-60) / .05 mL in 1 SYRINGE, GLASSMarketed from Mar 9, 2022
0078-0827-98	00078082798	1 SYRINGE, GLASS in 1 CARTON (0078-0827-98) / .05 mL in 1 SYRINGE, GLASSMarketed from Mar 9, 2022 · Sample package

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Beovu
Generic name (nonproprietary): brolucizumab
Active ingredients: Brolucizumab — 6 mg/.05mL
Dosage form: Injection, Solution
Route: Intravitreal
Labeler: Novartis Pharmaceuticals CorporationNDC labeler code 0078
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761125
Marketing start: Oct 7, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 0078-0827_8b8e71f4-7d7e-40b5-a942-89ac3b6c0c6cSPL ID 8b8e71f4-7d7e-40b5-a942-89ac3b6c0c6cSPL set ID 5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3dRxCUI 2204920, 2204925, 2602276, 2602279UNII XSZ53G39H5

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400078082760 followed by a unit qualifier and the quantity

Package 00078-0827-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 3, 2025.

Indications (excerpt from the label)

BEOVU ® is indicated for the treatment of: BEOVU is a human vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of: Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1.1 ) Diabetic Macular Edema (DME) ( 1.2 ) 1.1 Neovascular (Wet) Age-related Macular Degeneration (AMD) 1.2 Diabetic Macular Edema (DME)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0078-0827

What is NDC 0078-0827?: 0078-0827 is the product NDC for Beovu (brolucizumab), Brolucizumab 6 mg/.05mL injection, solution, listed with the FDA by Novartis Pharmaceuticals Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Beovu (Brolucizumab).
What is the active ingredient?: Brolucizumab.
Who is the labeler?: Novartis Pharmaceuticals Corporation, NDC labeler code 0078. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Beovu?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Beovu (Brolucizumab) NDC 0078-0827